• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息性治疗对晚期胸腺癌患者的关键作用。

Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma.

作者信息

Nagamata Makoto, Okuma Yusuke, Yamada Yuko, Hosomi Yukio, Hishima Tsunekazu

机构信息

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

出版信息

Oncol Lett. 2014 Aug;8(2):513-516. doi: 10.3892/ol.2014.2217. Epub 2014 Jun 3.

DOI:10.3892/ol.2014.2217
PMID:25013463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4081363/
Abstract

Thymic carcinoma is a rare cancer that is more aggressive and shows a poorer prognosis compared with thymoma. Molecular analysis has demonstrated that this entity is clearly distinct from thymoma. However, no definitive clinical management has been reported, and the roles of chemotherapy and radiotherapy for advanced thymic carcinoma remain unclear given the rarity of this clinicopathology. The current study reports the case of a 65-year-old male who presented with advanced thymic carcinoma with solitary brain and pulmonary metastases, but demonstrated long-term survival following multiple lines of chemotherapy and radiotherapy with palliative intent. Although the solitary brain metastasis was well controlled for several years using whole-brain irradiation, cognitive function gradually declined with cerebral atrophy. Thymic carcinoma is known to show a poor prognosis and aggressive clinical progress, however, it occasionally demonstrates a clinically indolent course. Modalities of treatment should thus be selected prudently to avoid toxicity, in consideration of the possibility of long-term survival. Stereotactic radiation therapy for brain metastases, including cyberknife or γ-knife surgery, appears to represent the optimal local treatment for such patients with unexpectedly longer survival due to indolent thymic carcinoma.

摘要

胸腺癌是一种罕见的癌症,与胸腺瘤相比,其侵袭性更强,预后更差。分子分析表明,该实体与胸腺瘤明显不同。然而,尚未有明确的临床治疗方案报道,鉴于这种临床病理情况较为罕见,化疗和放疗在晚期胸腺癌中的作用仍不明确。本研究报告了一例65岁男性患者,其患有伴有孤立性脑转移和肺转移的晚期胸腺癌,但在进行了多线姑息性化疗和放疗后实现了长期生存。尽管通过全脑照射对孤立性脑转移进行了数年的良好控制,但随着脑萎缩,认知功能逐渐下降。胸腺癌已知预后较差且临床进展具有侵袭性,然而,它偶尔也会表现出临床惰性病程。因此,考虑到长期生存的可能性,应谨慎选择治疗方式以避免毒性。对于因惰性胸腺癌而意外获得较长生存期的此类患者,立体定向放射治疗,包括射波刀或伽玛刀手术,似乎是最佳的局部治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/a426c705eb58/OL-08-02-0513-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/16dc3c222f35/OL-08-02-0513-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/fa7063246b17/OL-08-02-0513-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/a426c705eb58/OL-08-02-0513-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/16dc3c222f35/OL-08-02-0513-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/fa7063246b17/OL-08-02-0513-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b92/4081363/a426c705eb58/OL-08-02-0513-g02.jpg

相似文献

1
Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma.姑息性治疗对晚期胸腺癌患者的关键作用。
Oncol Lett. 2014 Aug;8(2):513-516. doi: 10.3892/ol.2014.2217. Epub 2014 Jun 3.
2
Successful treatment of advanced thymic carcinoma with lymph node and pleural metastases: A case report.成功治疗伴有淋巴结和胸膜转移的晚期胸腺癌:一例报告。
Mol Clin Oncol. 2016 Nov;5(5):550-552. doi: 10.3892/mco.2016.1006. Epub 2016 Aug 26.
3
Stereotactic ablative radiotherapy with CyberKnife for advanced thymic carcinoma: a case report.射波刀立体定向消融放疗治疗晚期胸腺癌:病例报告
Curr Oncol. 2015 Oct;22(5):e391-4. doi: 10.3747/co.22.2693.
4
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment.胸腺癌的骨寡转移:一例提示姑息性放疗有效性的病例报告。
Onco Targets Ther. 2016 Feb 29;9:1029-32. doi: 10.2147/OTT.S98914. eCollection 2016.
5
A Case of Thymic Carcinoma with Bone and Cerebral Metastases Treated with Stereotactic Radiosurgery and Chemotherapy.1例胸腺癌伴骨和脑转移行立体定向放射外科治疗及化疗
Am J Case Rep. 2019 Nov 13;20:1669-1674. doi: 10.12659/AJCR.917982.
6
[Chemotherapy for thymic carcinoma].[胸腺癌的化疗]
Gan To Kagaku Ryoho. 2012 May;39(5):702-7.
7
Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.先前接受姑息性化疗的晚期胸腺癌患者对细胞毒性化疗的反应。
Clin Lung Cancer. 2015 May;16(3):221-7. doi: 10.1016/j.cllc.2014.10.006. Epub 2014 Oct 31.
8
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.胸腺上皮肿瘤的治疗:来自日本的1320例患者的临床研究。
Ann Thorac Surg. 2003 Sep;76(3):878-84; discussion 884-5. doi: 10.1016/s0003-4975(03)00555-1.
9
The potency of curative-intent treatment for advanced thymic carcinoma.治愈意图治疗晚期胸腺癌的疗效。
Lung Cancer. 2014 May;84(2):175-81. doi: 10.1016/j.lungcan.2014.02.012. Epub 2014 Mar 2.
10
Haemorrhagic brain metastasis from a thymic carcinoma.胸腺癌导致的出血性脑转移瘤。
J Clin Neurosci. 2004 Feb;11(2):190-4. doi: 10.1016/j.jocn.2003.05.001.

引用本文的文献

1
A case of chemorefractory metastatic type AB thymoma sensitive to helical tomotherapy.一例对螺旋断层放射治疗敏感的化疗难治性转移性AB型胸腺瘤病例。
Ann Transl Med. 2019 Jun;7(12):274. doi: 10.21037/atm.2019.05.34.
2
Response of mouse thymic cells to radiation after transfusion of mesenchymal stem cells.间充质干细胞输注后小鼠胸腺细胞对辐射的反应。
Medicine (Baltimore). 2016 Dec;95(51):e5295. doi: 10.1097/MD.0000000000005295.
3
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment.

本文引用的文献

1
Thymic epithelial tumours: from basic principles to individualised treatment strategies.胸腺上皮肿瘤:从基础原理到个体化治疗策略。
Eur Respir Rev. 2013 Mar 1;22(127):75-87. doi: 10.1183/09059180.00007312.
2
Clinical outcomes with chemotherapy for advanced thymic carcinoma.晚期胸腺癌化疗的临床疗效。
Lung Cancer. 2013 Apr;80(1):75-80. doi: 10.1016/j.lungcan.2012.12.012. Epub 2013 Jan 11.
3
Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.胸腺瘤和胸腺癌中受体酪氨酸激酶的蛋白表达和基因拷贝数变化。
胸腺癌的骨寡转移:一例提示姑息性放疗有效性的病例报告。
Onco Targets Ther. 2016 Feb 29;9:1029-32. doi: 10.2147/OTT.S98914. eCollection 2016.
Ann Oncol. 2012 Dec;23(12):3129-3137. doi: 10.1093/annonc/mds147. Epub 2012 Jun 13.
4
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.卡铂和紫杉醇治疗晚期胸腺瘤和胸腺癌的 II 期研究。
J Clin Oncol. 2011 May 20;29(15):2060-5. doi: 10.1200/JCO.2010.32.9607. Epub 2011 Apr 18.
5
Expression and mutational status of c-kit in thymic epithelial tumors.c-kit 在胸腺瘤中的表达与突变状态。
J Thorac Oncol. 2010 Sep;5(9):1447-53. doi: 10.1097/JTO.0b013e3181e96e30.
6
Thymic carcinoma: state of the art review.胸腺癌:最新综述
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):654-64. doi: 10.1016/j.ijrobp.2003.11.021.
7
The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.世界卫生组织组织学分类系统反映胸腺瘤的肿瘤行为:273例患者的临床研究
Cancer. 2002 Feb 1;94(3):624-32. doi: 10.1002/cncr.10226.
8
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.顺铂加阿霉素加环磷酰胺治疗转移性或复发性胸腺瘤:一项联合组试验的最终结果。东部肿瘤协作组、西南肿瘤协作组和东南癌症研究组。
J Clin Oncol. 1994 Jun;12(6):1164-8. doi: 10.1200/JCO.1994.12.6.1164.
9
Thymoma. Histologic subclassification is an independent prognostic factor.胸腺瘤。组织学亚分类是一个独立的预后因素。
Cancer. 1994 Jul 15;74(2):606-17. doi: 10.1002/1097-0142(19940715)74:2<606::aid-cncr2820740212>3.0.co;2-t.
10
Pathology of thymic epithelial tumors.胸腺上皮肿瘤的病理学
Curr Top Pathol. 1986;75:207-68. doi: 10.1007/978-3-642-82480-7_7.